TG Therapeutics continues strong execution with Briumvi, maintaining beat-and-raise performance and robust financials, including a new $100 million buyback program. However, high investor expectations ...
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number 27 on the Deloitte Technology Fast 500â„¢, a ranking of the 500 fastest-growing ...
MORRISVILLE, N.Y. (AP) — MORRISVILLE, N.Y. (AP) — TG Therapeutics Inc. (TGTX) on Monday reported third-quarter net income of $390.9 million. On a per-share basis, the Morrisville, New York-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback